Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pavmed Inc Series Z WT (PAVMZ)

Pavmed Inc Series Z WT (PAVMZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 2,995 K
  • Annual Income, $ 39,791 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0008 +12.50%
on 04/30/25
0.0061 -85.25%
on 04/01/25
-0.0047 (-83.93%)
since 03/28/25
3-Month
0.0008 +12.50%
on 04/30/25
0.0187 -95.19%
on 02/03/25
-0.0095 (-91.35%)
since 01/30/25
52-Week
0.0008 +12.50%
on 04/30/25
0.0720 -98.75%
on 05/17/24
-0.0415 (-97.88%)
since 04/30/24

Most Recent Stories

More News
PAVmed and Lucid Diagnostics Provide Strategic Business Update

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
PAVmed and Lucid Diagnostics to Provide Strategic Business Update

PAVmed Inc. (Nasdaq: PAVM, PAVMZ), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiaries...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
PAVmed Partners with Novosound on Ultrasound Imaging Technology

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
PAVmed Digital Health Subsidiary Veris Health Launches Veris Cancer Care Platform

PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today announced...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
Lucid Diagnostics Selected as Finalist for Medtech Company of the Year 2022 by Medical Device + Diagnostic Industry

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq:...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
Lucid Diagnostics Presents Real-World EsoCheck Data at the American Association for Cancer Research

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”),...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid” or the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
PAVmed to Participate in BTIG Digital Health Forum

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”, the “Company”), a diversified commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors,...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)
Lucid Diagnostics Commences Production of EsoCheck Devices with High-Volume Manufacturer

Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM,...

PAVMZ : 0.0009 (-40.00%)
LUCD : 1.2100 (unch)
PAVM : 6.19 (-5.93%)

Key Turning Points

3rd Resistance Point 0.0029
2nd Resistance Point 0.0024
1st Resistance Point 0.0017
Last Price 0.0009
1st Support Level 0.0005
2nd Support Level 0.0000
3rd Support Level N/A

See More

52-Week High 0.0720
Fibonacci 61.8% 0.0448
Fibonacci 50% 0.0364
Fibonacci 38.2% 0.0280
Last Price 0.0009
52-Week Low 0.0008

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar